Regencell Bioscience (RGC) has had the highest return since January 1, 2025 by a US stock with a market cap of $2,024+, returning 9,825.1%.
| ASSET | % RETURN |
|---|---|
Regencell Bioscience (RGC) | 9,825.15% |
CannBioRx Life Sciences (ATNFW) | 4,287.76% |
WW International, Inc Common Stock (WW) | 2,215.27% |
DeFi Development (DFDV) | 2,123.21% |
Zepp Health (ZEPP) | 1,822.31% |
Diginex Limited Ordinary Shares (DGNX) | 1,430.28% |
Lizhi (SOGP) | 1,334.09% |
FiEE (FIEE) | 1,221.1% |
Abivax SA American Depositary Shares (ABVX) | 1,115.88% |
Airnet Technology (ANTE) | 1,039.93% |
Oncology Institute (TOI) | 978.43% |
Anbio Biotechnology Class A Ordinary Shares (NNNN) | 809.7% |
Asset Entities Inc Class B Common Stock (ASST) | 808% |
Global Interactive Technologies (GITS) | 742.32% |
ThredUp (TDUP) | 705.56% |
Americas Silver (USAS) | 621.41% |
Nova Lifestyle I (NVFY) | 565.66% |
Dominari (DOMH) | 544.77% |
NovaBay Pharmaceuticals (NBY) | 532.2% |
Lixte Biotechnology (LIXTW) | 507.14% |
M3-Brigade Acquisition V Corp Warrant (MBAVW) | 493.82% |
QMMM Holdings Limited Ordinary Shares (QMMM) | 489.92% |
Newegg Commerce (NEGG) | 451.5% |
Epsium Enterprise Limited Ordinary Shares (EPSM) | 446.21% |
Abits (ABTS) | 445.45% |
